top of page
This site was designed with the
.com
website builder. Create your website today.Start Now

  1. Renno, T., Lin, J. Y., Piccirillo, C., Antel, J., and Owens, T.  "Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. "  J. Neuroimmunol.  49: 1-7, 1994.

  2. Renno, T., Krakowski, M., Piccirillo, C., and Owens, T.  "TNF-alpha expression by resident microglia and infiltrating leukocytes in the CNS of mice with experimental allergic encephalomyelitis.  Regulation by Th1 cytokines. " J. Immunol. 154: 944-953, 1995.

  3. Piccirillo, C.A., Chang, Y., and Prud’homme, G. J.  "TGF-b1 somatic gene therapy prevents autoimmune disease in NOD mice."  J. Immunol.  161: 3950-3956,1998.

  4. Piccirillo, C.A., and Prud’homme, G. J.  "Prevention of experimental allergic encephalomyelitis by intramuscular injection of cytokine-encoding plasmid DNA expression vectors." Human Gene Therapy 10: 1915-1922, 1999.

  5. Piccirillo C. A., Shevach E.M. "Cutting edge: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells." J. Immunol.167:1137-1140, 2001.

  6. McHugh, R. S., M. J. Whitters, C. A. Piccirillo, D. A. Young, E. M. Shevach, M. Collins, and M. C. Byrne. "Gene expression analysis of CD4+CD25+ immunoregulatory T cells: A unique cell phenotype and a functional role for the Glucocorticoid-induced TNF receptor." Immunity 16: 311-323, 2002.

  7. Piccirillo, C. A., J.J. Letterio, A. M.Thornton, R. S. McHugh, M. Mamura, H. Mizuhara, and E. M. Shevach. "CD4+CD25+-mediated suppression of T cell activation in vitro is independent of TGF-b1 production and responsiveness."  J. Exp. Med. 196:237-246, 2002.

  8. Belkaid, Y. *, C. A. Piccirillo*, S. Mendez, E. M. Shevach and D. L. Sacks. "CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity." Nature 420:502-7, 2002.   * Equal contribution/co-first authors

  9. Piccirillo C.A. and G.J. Prud'homme. “Gene therapy with plasmids encoding cytokine- or cytokine receptor-IgG chimeric proteins.”  Methods in Molecular Biology: Cytokines and Colony Stimulating Factors: Methods and protocols. Humana Press, 215:153-70, 2003.

  10. Piccirillo C.A. and Prud'homme G.J. “Immune modulation by plasmid DNA-mediated cytokine gene transfer". Current Pharmaceutical Design. 9, 83-94, 2003.

  11. Piccirillo C.A.  and E. M. Shevach. FOCUS-Viewpoint article "CD4+CD25+ immunoregulatory T cells: naturally-occurring but adaptable." Nature Reviews in Immunology 3, 2003.

  12. Shevach E.M., C. A. Piccirillo, A. M. Thornton and R. S. McHugh. "Control of T cell activation by CD4+CD25+ suppressor T cells." Novartis Symposia 252:24-36. 2003.

  13. Hesse M., C. A Piccirillo, Y. Belkaid, J. Prufer, M. Mentink-Kane, M. Leusink, A. W. Cheever, E. M. Shevach, and T. A. Wynn. "CD4+CD25+ regulatory T cells are the major source of host protective IL-10 in murine schistosomiasis." J. Immunol. 172; 3157-3166, 2004.

  14. Piccirillo, C.A., and A.M. Thornton. "Cornerstone of peripheral tolerance: naturally-occurring CD4+CD25+ regulatory T cells." Trends in Immunol. 25, 374-380. 2004. * Senior author.

  15. Piccirillo, C.A. and E. M. Shevach. "Naturally-occurring CD4+CD25+ immunoregulatory T cells: Central players in the arena of peripheral tolerance." Semin. Immunol. 16; 81-88. 2004.

  16. Thornton A.M, C.A. Piccirillo and E.M Shevach. "Cytokine and costimulatory requirements for induction of CD4+CD25+suppressor effector function." Euro. J.  Immunol. 34; 366-376, 2004.

  17. Thornton A. M., E. Donovan, C. A. Piccirillo and E. M. Shevach. "IL-2 is critically required for activation of the suppressor function of CD4+CD25+ T cells in vitro." J. Immunol 172: 6519-6523, 2004.

  18. Mendez S., S. K. Reckling, C. A.  Piccirillo, D.Sacks, Y.Belkaid. "Role for CD4+CD25+ regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity." J Exp Med. 200:201-10, 2004.

  19. Antony, P. A., C.A. Piccirillo, A. Akpinarli, S.E. Finkelstein, P.J. Speiss, D.R. Surman, D.C. Palmer, C.C. Chan, C.A. Klebanoff, W.W. Overwijk, S.A. Rosenberg, and N.P. Restifo. "CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells."  J. Immunol. 174, 2591-601. 2005

  20. C. A. Piccirillo. "Helper and Regulatory T lymphocytes."  McGraw-Hill Yearbook of Science and Technology. 2005. P.134-137.

  21. Kullberg M., V. Hay, A. Sher, J. J. Letterio E. M. Shevach, and *C.A. Piccirillo. "TGFb1-independent control of mucosal inflammation mediated by naturally-occurring CD4+CD25+ regulatory T cell in vivo." Eur. J. Immunol. 35: 2886–2895, 2005.

  22. C.A. Piccirillo, M. Tritt, E. Sgouroudis, A. Albanese, M. Pyzik, and V. Hay. "Control of type 1 autoimmune diabetes by naturally-occurring CD4+CD25+ regulatory T lymphocytes." Annals of NY. Acad. Sci. 1051, 72-87, 2005. * Senior author.

  23. Piccirillo, C.A. “Tolerogenic functions of naturally-occurring CD4+CD25+ regulatory T lymphocytes.” Altered immunoregulation and human disease: Regulation and development of T cell tolerance, R. Gorzynski, Ed. Publishing House ed. (2005).

  24. Piccirillo C.A., A. N. Theofilopoulos, and G. J. Prud’homme. “Immunogene therapy with non-viral vectors.” Gene Therapy for Atoimmune Disease. G. J. Prud’homme, Ed. Landes Bioscience and Klunes/Plenus Publishers. (2005).

  25. Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y. "Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens." J. Exp Med. 203, 777-788, 2006.

  26. Manigold T., K. Mihalik, C.M. Rice, S.M. Feinstone, C. A. Piccirillo, B. Rehermann. "Foxp3+CD4+CD25+ Regulatory T Cells Control virus-specificmemory T cells in chimpanzees that recovered from hepatitis C." Blood 107:4424-4432. 2006

  27. Yurchenko K., H. Friedman, A. Peterson and *C.A. Piccirillo.  "Development of a mouse model ubiquitously expressing mRFP-1 by site-directed transgenesis." Transgenic Research 16:29-40; 2006.

  28. Yurchenko K., M. Tritt, V. Hay, Belkaid Y., and *C.A. Piccirillo. "CCR5-dependent recruitment of naturally-occurring CD4+CD25+ regulatory T cells in sites of chronic infection favors pathogen persistence." J. Exp. Med. 203:2451-60; 2006.

  29. Toda, A. and C.A.Piccirillo*. "Development and functions of naturally-occurring CD4+CD25+ regulatory T cells." J. Leuko. Biol. 80, 1-13. 2006.

  30. Levings, M.K., S.E. Allan, E.d’Hennezel, and C.A. Piccirillo*. "Functional dynamics of CD4+FoxP3+ regulatory T cells in health and disease." Adv. In Immunol. 92; 119-155. 2006.

  31. Douglas K.L., C.A. Piccirillo, M.Tabrizian. "The Effect of Alginate Inclusion on the Vector Properties of Chitosan-Based Nanoparticles." J. Control Release 115;354-361, 2006.

  32. Pyzik M., and *C.A. Piccirillo. "TGF-1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets." J Leuko.Biol. 82:335-46; 2007.

  33. Segura, M., Z. Su, C.A. Piccirillo, and M.M. Stevenson. "Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression." Euro J. Immunol. 37:1887-904; 2007

  34. Douglas K.L., M.Tabrizian, and C.A. Piccirillo. "Cell Line-Dependent Internalization Pathways and Intracellular Trafficking Determine Transfection Efficiency of Nanoparticle Vectors." Euro J of Pharm. and Biopharm. ;68(3):676-87.2008.

  35. Piccirillo, C.A. "CD4+Foxp3+ regulatory T cells in the control of immunological tolerance." Regulatory T cells. Shuiping Liang, Ed. Springer Publishers, Inc. New York. June 2008.

  36. Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK. "The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease." Immunology 125(2):145-53; 2008.

  37. C.A. Piccirillo. "Immune regulation mediated by CD4+Foxp3+ regulatory T cells." Cytokine 43(3):395-401; 2008.

  38. R. Pelanda and C.A. Piccirillo. "Tolerance, immune regulation and autoimmunity: cells and cytokines that make a difference." Current Opinion in Immunol. 20:629-631; 2008

  39. C.A. Piccirillo, E. d’Hennezel, E. Sgouroudis, and E. Yurchenko. "CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas." Current Opinion in Immunology 20:655-662; 2008

  40. Sgouroudis E. and C.A. Piccirillo. "Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: Lessons from mouse models and implications for human disease." Diabetes/Metabolism Research and Reviews 2009.

  41. Giroux, M., J. St-Pierre, K. Yurchenko, C. A. Piccirillo and C. Perreault. "T Regulatory Cells Control Numbers of NK Cells and CD8{alpha}+ Immature Dendritic Cells in the Lymph Node Paracortex." J Immunol. 179:4492-502; 2007

  42. M. Tritt, E. Sgouroudis, E. d’Hennezel, A. Albanese and *C.A. Piccirillo. "Functional waning of naturally-occurring CD4+ regulatory T cells contributes to the onset of autoimmune diabetes." Diabetes 57:113-23; 2008.

  43. M. Tritt, E. Sgouroudis, E. d’Hennezel, A. Albanese and *C.A. Piccirillo. "Response to Comment on: Tritt et al. (2007) Functional Waning of Naturally Occurring CD4+Regulatory T-Cells Contributes to the Onset of Autoimmune Diabetes." Diabetes 57: e7-e8, 2008

  44. Tang Q., J.Y. Adams, C.Penaranda, K.Grossheider, E.Piaggio, E.Sgouroudis, C.A. Piccirillo, B.L. Salomon, and J.A.Bluestone. "Central role of a defective IL-2 production in triggering islet autoimmune destruction." Immunity 28(5):687-97, 2008.

  45. Sgouroudis E., A. Albanese, and *C.A. Piccirillo. "Functional impact of Idd3 alleles on the development of naturally-occurring CD4+Foxp3+ regulatory T lymphocytes and resistance to autoimmune diabetes." J. of Immunology 181(9): 6283-6292; 2008.

  46. d'Hennezel E. , Ben-Shoshan M., Ochs H.D. , Torgerson T.R., Russell L.J. , Lejtenyi C., Noya F.J.,  Jabado N. , Mazer B. and Piccirillo C.A. "Functional evaluation of regulatory T cells in IPEX caused by a missense mutation in the FOXP3 forkhead domain." New England Journal of Medicine, 361(17):1710-17133, 2009

  47. Ursini-Siegel, S.M. Cory, D.Zuo, W. R.Hardy, E.Rexhepaj, S. H.L. Lam, B.Schade, K. Jirstrom, E. Bjur, C.A. Piccirillo, D.DeNardo, L.M. Coussens, D.J. Brennan, W.M. Gallagher, M.Park, T. Pawson, M.Hallett and W.J. Muller. "Receptor Tyrosine Kinase Signaling Favors a Pro-Tumorigenic State in Breast Cancer Cells by Inhibiting the Adaptive Immune Response." Cancer Research 2010 Oct 15;70(20):7776-87.

  48. d’Hennezel, M. Kornete and C.A. Piccirillo. "IL-2 as a therapeutic target for the restoration of Foxp3+ regulatory T cell function in organ-specific autoimmunity: Implications in pathophysiology and translation to human disease." Journal of Translational Medicine 2010 Nov 8;8:113.

  49. Piccirillo C.A. "Treg’s Alter Ego: An Accessory in Tumor Killing." Immunity 2010;33:838-40.

  50. Himmel M.E., S.Q. Crome, S.Ivison, C.Piccirillo, T.S.Steiner, and M.K. Levings. "Human CD4+FOXP3+ T Regulatory cells produce CXCL8 and recruit neutrophils." Euro. J. Immunology 2011 Feb;41(2):306-12.

  51. Sgouroudis E. , M Kornete and C.A. Piccirillo. "Il-2 allelic variation modulates dendritic cell-mediated potentiation of CD4+Foxp3+ regulatory T cell function and resistance to autoimmune diabetes." Autoimmunity 2011;44(5):406-14

  52. Dieudé M., H. Striegl, J.Wang, S.M. Behar, C.A. Piccirillo, J.S. Levine, D.M. Zajonc, and J.Rauch.  "Cardiolipin Binds to CD1d and Stimulates CD1d-Restricted gd T cells in the Normal Murine Repertoire."  J. of Immunology 2011;186(8):4771-81.

  53. G. N. Kaufman, A. H. Massoud, S. Audusseau, A.-A. Banville-Langelier, Y. Wang, J. Guay, J. A. Garellek,W. Mourad, C. Piccirillo, C. McCusker and B. D. Mazer. "Intravenous immunoglobulin attenuates airway hyperresponsiveness in a murine model of allergic asthma." Clinical and Experimental Allergy 2011;41(5):718-28

  54. Bacheli D., V. Hay, J. Nadeau, and C.A. Piccirillo. "A role for trogocytosis in CD4+Foxp3+ regulatory T cell contact-dependent suppression." Autoimmunity 44(8):607-15. 2011.

  55. F. Berretta, St-Pierre J., C.A. Piccirillo* and M.M Stevenson*. "Interleukin 2 contributes to maintaining a balance between CD4+ Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection." J. of Immunology 2011;186(8):4862-71. * co-senior authors

  56. d’Hennezel E. , E. Yurchenko, E. Sgouroudis, V. Hay, C. A. Piccirillo*. "Single-cell analysis of the human TReg population uncovers functional heterogeneity and instability within FOXP3+ cells." J. of Immunology 2011;186(12):6788-97.

  57. C. Grange, J. Létourneau, M-A. Forget, J.Godin-Ethier, J. Martin, M. Liberman, M. Latour, H. Widmer, C.A. Piccirillo, J-B. Lattouf, J-P.Cailhier and R. Lapointe. "Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation." J. Immunol. Methods 30;372(1-2):119-26; 2011.

  58. Yurchenko K., M. Levings and C.A. Piccirillo. "CD4+Foxp3+ regulatory T cells directly suppress gd T cell effector functions in a model of T cell-induced mucosal inflammation." European Journal of Immunology, 2011;41(12):3455-66

  59. d'Hennezel E, and Piccirillo CA. "Analysis of human FOXP3+ TReg cells phenotype and function. Regulatory T-Cells: Methods and Protocols." Methods Mol Biol. ;707:199-218, 2011

  60. Godin-Ethier J. , L.-A.Hanafi, C. A. Piccirillo and R. Lapointe. "Indoleamine 2,3-dioxygenase expression in human cancer: clinical and immunological perspectives." Clinical Cancer Research 17(22):6985-91; 2011

  61. Kornete M., and C.A. Piccirillo. "Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I Diabetes." Autoimmunity Reviews 11(2):104-11; 2011

  62. G. Hardenberg, Y.Yao, C.A. Piccirillo M.K. Levings, and T.S. Steiner. "Toll-like receptor 5 deficiency protects from wasting disease in a T cell transfer colitis model in T cell receptor beta deficient mice." Inflamm. Bowel Disease 2012;18(1):85-93.

  63. Vinh DC, Bin Dhuban K, Mason H, Lejtenyi D, Jung S, Sheppard D, Faury D, Jabado N, Piccirillo CA. "Acquired Omenn-like Syndrome: a novel post-transplant autoaggression syndrome reversed by rapamycin." Clin. Vaccine Immunol. 2012;19(1):109-12.

  64. Da Silva Martins M., and C.A. Piccirillo. "Functional plasticity of Foxp3+ regulatory T cells." Trends Mol Med. 2012 Aug;18(8):454-62. Epub 2012 Jul 6.

  65. E. d’Hennezel, K.Bin Dhuban, T. Torgerson, C. A. Piccirillo. "The immunogenetics of Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) syndrome." J. Med. Genet. 2012 May;49(5):291-302.

  66. d’Hennezel E. and C. A. Piccirillo. "Functional plasticity in human FOXP3+ regulatory T cells: Implications for cell-based immunotherapy." Hum Vaccin Immunother. 2012 Jul 1;8(7):1001-5. doi: 10.4161/hv.20203. Epub 2012 Jul 1.

  67. Kornete M., and C.A. Piccirillo. "Functional crosstalk between dendritic cells and Foxp3+ regulatory T cells in the maintenance of immune tolerance." Front Immunol. 2012;3:165. Epub 2012 Jun 22.

  68. Kornete M., and E. Sgouroudis, and C.A. Piccirillo. "ICOS-dependent homeostasis and function of Foxp3+ regulatory T cells in islets of NOD mice." J. Immunlogy 2012 188:1064-74.

  69. Massoud A.H., Y. Nouhi, J.Guay, K.Shalaby, A.Ablona, D.Chan, E. Bjur, W.Mourad, C.A. Piccirillo*, and B. Mazer*. "Intravenous immune globulin attenuates airway hyper-responsiveness via the induction of Foxp3+ Treg cells in a murine model of allergic asthma." (Co-senior author) J Allergy Clin Immunol. 2012 Jun;129(6):1656-65.e3. Epub 2012 May 5, Editor’s Choice.

  70. Yurchenko K., M.Shio, T.C. Huang, M. Szyf, M.Levings, M. Olivier and C.A. Piccirillo. "Inflammation-driven reprogramming of CD4+Foxp3+ regulatory T cells into pathogenic Th1 and Th17 effectors is reversible by mTOR inhibition in vivo." PLoS One. 2012;7(4):e35572. Epub 2012 Apr 24.

  71. Khalili S., Y.Liu, M.Kornete, N. Roescher, S.Kodama, A.Peterson, C.A. Piccirillo and S.D. Tran. "Mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in Sjögren's syndrome." PLoS One. 2012;7(6):e38615. Epub 2012 June 7.

  72. Kornete M., H. Beauchemin, C. Polychonakos and C.A. Piccirillo. "Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice." Autoimmunity Epub Feb 4, 2013.

  73. Bjur, E., Larsson, O., Yurchenko E., Zheng L., Topisirovic, I, Sonenberg, N., Piccirillo, C.A. "Distinct translation control of gene expression in CD4+Foxp3+ regulatory T cells." PLoS Genetics, May;9(5):e1003494.2013.

  74. Li J, Heinrichs J, Leconte J, Haarberg K, Semple K, Liu C, Gigoux M, Kornete M, Piccirillo CA, Suh WK, Yu XZ. "Phosphatidylinositol 3-Kinase-Independent Signaling Pathways Contribute to ICOS-Mediated T Cell Costimulation in Acute Graft-Versus-Host Disease in Mice." J Immunol. 2013 Jul 1;191(1):200-7. Epub 2013 May 31.

  75. Liston A. and C.A. Piccirillo.  "Developmental plasticity of murine and human commitment of Foxp3+ regulatory T cells." (commissioned by journal). Adv Immunol. 2013;119:85-106. doi: 10.1016/B978-0-12-407707-2.00003-5.

  76. M. Kornete, E. Mason and C.A. Piccirillo. "Immune Regulation in T1D and T2D: Prospective Role of Foxp3+ Treg Cells in Disease Pathogenesis and Treatment." Front Endocrinol. 2013 Jun 25;4:76. doi: 10.3389/fendo.2013.00076.

  77. Piccirillo C.A. "Environmental sensing and regulation of gene expression in CD4+ T cell subsets." Current Opinion in Immunology 2013 Oct;25(5):564-70. doi: 10.1016/j.coi.2013.09.006. Epub 2013 Oct 17.

  78. Bin Dhuban K., d'Hennezel E., Ben-Shoshan M., McCusker C., Clarke A. Fiset P., Mazer B., and Piccirillo C.A. "Altered Th17 Responses in Children with Food Allergy." International Archives in Allergy and Immunology, 2013;162(4):318-22. doi: 10.1159/000354028. Epub 2013 Oct 25.)

  79. Belabani C, Rajasekharan S, Poupon V, Johnson T, Bar-Or A CIHR/MSSC NET in Clinical Autoimmunity; Canadian Pediatric Demyelinating Disease Network. "A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samples." J Immunol Methods. 2013 Jan 31;387(1-2):1-10.

  80. Massoud A.H., M.Yona, A.Ablona, M. W.Mourad, C.A. Piccirillo, B.D. Mazer. "Dendritic Cell Immunoreceptor (DCIR) Mediates the Tolerogenic Effects of Intravenous Immunoglobulin in pulmonary inflammation." J Allergy Clin Immunol. 2013 Nov 7. pii: S0091-6749(13)01476-0. doi: 10.1016/j.jaci.2013.09.029.

  81. Zouk H, D'Hennezel E, Du X, Ounissi H, Piccirillo CA, Polychronakos C. "Functional evaluation of the role of CLEC16A at the chromosome 16p13 locus". Clin Exp Immunol. 2013 Nov 18. doi: 10.1111/cei.12240.

  82. Dionne S, Calderon MR, White JH, Memari B, Elimrani I, Adelson B, Piccirillo C, Seidman EG. "Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease." Mucosal Immunol. 2014 Apr 30. doi: 10.1038/mi.2014.30.

  83. Lafferty E., Flaczyk A., Angers I., Homer R., d'Hennezel E., D. Malo, C. Piccirillo, S.Vidal and S. Qureshi. "An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following Influenza A H1N1 infection." Genes and Immunity May 22. doi: 10.1038/gene.2014.22. 2014.

  84. Khalid Bin Dhuban, M. Kornete, E.Mason and C.A. Piccirillo. "Functional dynamics of Foxp3+ regulatory T cells in mice and humans." Immunological Reviews 2014 May;259(1):140-58. doi: 10.1111/imr.12168.

  85. Piccirillo C.A. E. Bjur, I. Topisirovic, N. Sonenberg, and O. Larsson. "Translational control of immune responses: from transcripts to translatomes." Nature Immunology 2014 Jun;15(6):503-11. doi: 10.1038/ni.2891.

  86. Invited Guest Editor, Pagliari D, Piccirillo CA, Larbi A, Cianci R. "The Interactions between Innate Immunity and Microbiota in Gastrointestinal Diseases." J Immunol Res. 2015;2015:898297. doi: 10.1155/2015/898297. Epub 2015 May 20.

  87. Bin Dhuban K, Piccirillo CA "The immunological and genetic basis of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome." Curr Opin Allergy Clin Immunol. 2015 Dec;15(6):525-32. doi: 10.1097.

  88. Kaufman GN, Massoud AH, Dembele M, Yona M, Piccirillo CA, Mazer BD. "Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity." Front Immunol. 2015 Sep 11;6:469. doi: 10.3389/fimmu.2015.00469. 2015.

  89. Blagih J., G. Galicia-Vázquez, F. Dupuy, E. Yurchenko, G. van der Windt, B. Viollet, E. Pearce, J. Pelletier, C.A. Piccirillo, C. Krawczyk, M. Davingahi and R. Jones. "The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo." Immunity. 2015 Jan 20;42(1):41-54. 2015).

  90. Kornete M., E. Mason, J. Girard and C.A. Piccirillo. "Th1-like ICOS+ Foxp3+ Treg cells preferentially express CXCR3 and home to β-islet during pre-diabetes in NOD mice." PLoS One. 2015 May 6;10(5):e0126311. doi: 10.1371/journal.pone.0126311.

  91. Bin Dhuban K., E.d'Hennezel, E. Nashi, A.Bar-Or, S.Rieder, E.M. Shevach, S.Nagata and C.A. Piccirillo* "Co-expression of TIGIT and FCRL3 identifies memory Helios+ human Treg cells." J Immunol. 2015 Apr 15;194(8):3687-96. doi: 10.4049/jimmunol.1401803 2015.

  92. Istomine R, Pavey N, Piccirillo CA. "Posttranscriptional and Translational Control of Gene Regulation in CD4+ T Cell Subsets." J Immunol. 2016 Jan 15;196(2):533-40. doi: 10.4049/jimmunol.1501337.

  93. Pesenacker AM, Wang AY, Singh A, Gillies J, Kim YW, Piccirillo CA, Nguyen D, Haining WN, Tebbutt SJ, Panagiotopoulos C, Levings MK. "A Treg gene signature is a specific and sensitive biomarker to identify children with new onset type 1 diabetes." Diabetes. 2016 Jan 19. pii: db150572.

  94. M. Li, Beauchemin H., Popovic N., Peterson A., d’Hennezel E., Piccirillo C., Sun C., Polychronakos C.. The common, autoimmunity-predisposing 620Arg>Trp variant of PTPN22 modulates macrophage function and morphology J. of Autoimmunity 2017.

  95. K. Bin Dhuban, d'Hennezel E., Y. Nagai, Y. Xiao, S. Shao, F. Alvarez, R. Istomine, Ben-Shoshan M., Ochs H.D. , Mazer B.,  W. Hancock, Torgerson T.R , M. Greene, and Piccirillo C.A. Suppression by human FOXP3+ Treg cells requires FOXP3-TIP60 interactions Science Immunology 2017.

  96. Kornete M., E. Mason, R. Istomine and C.A. Piccirillo. KLRG1 expression identifies short-lived Foxp3+ Treg effector cells with functional plasticity in islets of NOD mice. Autoimmunity 2017.

bottom of page